Drugs / APHD 002
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07008456 Comparator | Sep 2025 → Jul 2026 overdue | morbid obesity | Aphaia Pharma US LLC | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | APHD 002 | “dextrose beads formulations (APHD 012 and APHD 002) combined with a gel composition” NCT07008456 ↗ |